14 KIT
Further progress on
diabetes tech
Diabetes technology news is coming out thick and fast.
Read about Abbott's Libre 3, CamAPS's new partner
YspoMed mylife insulin pump, as well as how CGMs
are likely to start being used by more hospitals to
monitor inpatients while Glooko buys up DiabNext.
By Sue Marshall
It is in part due to the pandemic that there is now so
much news about medical devices. Some have been a
long time in development, but are coming to fruition
now. As well as new products - or improved products,
there are also new partnerships especially as more
devices from separate manufactures are starting to 'talk'
to each other. Exciting times.
ABBOTT
Abbott, the global healthcare company, today announced
that its FreeStyle Libre 3 continuous glucose monitoring
(CGM) system, the latest addition to the world-leading
FreeStyle Libre sensor technology, is now available for use
in the UK.
The FreeStyle Libre 3 system is available via the
NHS Supply Chain Framework for people with more
complex diabetes management needs who require a
real-time CGM device. For example, those with impaired
hypoglycaemia awareness.
The FreeStyle Libre 3 system automatically delivers
continuous, real-time glucose readings every minute to
users' smartphones2 and provides 14 days of unsurpassed
accuracy4 with the smallest and thinnest1 sensor design
available. As a result, glucose monitoring with Abbott's
FreeStyle Libre 3 system is even more convenient and
discreet3.
The sensor, which is only the size of a £1 coin, is
worn on the back of the upper arm for up to 14 days.
Reducing the system's total volume by more than 70%,i
Abbott designed the FreeStyle Libre 3 system to be
more sustainable for the environment, including a 41%
reduction in plastic and 43% decrease in carton paper.5
The system comprises the sensor and the FreeStyle
Libre 3 smartphone app2, which allows users to record
their real-time glucose levels, glucose history and trend
arrows and see them every minute. A quick glance
at their compatible smartphone is all it takes to see
changes in glucose levels and adjust their diabetes
management accordingly.
Neil Harris, General Manager, Abbott's UK and Ireland
diabetes care business explained, "At Abbott, we are
proud to bring the FreeStyle Libre 3 system to the UK
for people with diabetes. For those people with more
complex diabetes management needs, the system aims
to make management easier and more convenient by
providing a continuous picture of their glucose levels in
real-time, as well as where they are heading."
Get on board!
Eligibility criteria for real-time CGM can be found on
the Diabetes UK or JDRF websites. Those who think
they may be eligible should discuss with their healthcare
professional at their next routine appointment.
The FreeStyle Libre 3 app is initially available for
Abbott's FreeStyle Libre 3 in action!